Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lameditech Co., Ltd. (462510:KRX), powered by AI.
Lameditech Co., Ltd. is currently trading at ₩6,010. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Lameditech Co., Ltd. on Alpha Lenz.
Lameditech Co., Ltd.'s P/E ratio is -4.7.
“Lameditech Co., Ltd. trades at a P/E of -4.7 (undervalued) with modest ROE of -82.4%. 3Y revenue CAGR of 51.8% highlights clear growth momentum.”
Ask for details →Lameditech Co., Ltd. is a South Korean company engaged in the development and production of medical devices with a focus on dental and dermatological applications. Its core function is to innovate medical technologies that enhance patient care and reduce procedural discomfort. One of Lameditech's notable products is its painless laser-based blood collection device, which is revolutionizing blood sampling methods. The company is a pioneer in integrating laser technology into routine medical procedures, making processes safer and more efficient. This focus positions Lameditech within crucial healthcare sectors as it serves hospitals, clinics, and research institutions. Headquartered in Suwon, South Korea, Lameditech's contributions to healthcare technology align with the growing demand for advanced medical solutions in both domestic and international markets. Through continued innovation, Lameditech Co., Ltd. plays a significant role in improving healthcare outcomes and broadening access to sophisticated yet patient-friendly medical technologies.
“Lameditech Co., Ltd. trades at a P/E of -4.7 (undervalued) with modest ROE of -82.4%. 3Y revenue CAGR of 51.8% highlights clear growth momentum.”
Ask for details →Lameditech Co., Ltd. (ticker: 462510) is a company listed on KRX in the Healthcare sector (Medical Devices). Market cap is $52.9B.
The current price is ₩6,010 with a P/E ratio of -4.65x and P/B of 6.28x.
ROE is -82.45% and operating margin is -164.78%. Annual revenue is $7.2B.